<html>
<head>PUBMED IDs for DBC2</head>
<body bgcolor='#C5F0F2'><h1>DBC2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12370419/'>DBC2, a candidate for a tumor suppressor gene involved in breast cancer.</a> October 9  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/15663929/'>DBC2 significantly influences cell-cycle, apoptosis, cytoskeleton and membrane-trafficking pathways.</a> January 25  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15922864/'>Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.</a> June 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17023000/'>DBC2 is essential for transporting vesicular stomatitis virus glycoprotein.</a> October 7  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17517369/'>Cyclin D1 down-regulation is essential for DBC2's tumor suppressor function.</a> May 23  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17617377/'>DBC2 resistance is achieved by enhancing 26S proteasome-mediated protein degradation.</a> July 10  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17653899/'>Mutation analysis of the DBC2 gene in sporadic and familial breast cancer.</a> July 27  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17906984/'>Genetic analysis of the DBC2 gene in gastric cancer.</a> October 2  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17906980/'>Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?</a> October 2  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18039672/'>RhoBTB2 (DBC2) is a mitotic E2F1 target gene with a novel role in apoptosis.</a> November 28  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18640857/'>DBC2 gene is silenced by promoter methylation in bladder cancer.</a> July 22  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18762809/'>The atypical Rho GTPase RhoBTB2 is required for expression of the chemokine CXCL14 in normal and cancerous epithelial cells.</a> September 3  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19937980/'>A novel tumor suppressor gene RhoBTB2 (DBC2): frequent loss of expression in sporadic breast cancer.</a> March 26  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20930524/'>Ectopic expression of RhoBTB2 inhibits migration and invasion of human breast cancer cells.</a> June 29  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21801820/'>RhoBTB2 (DBC2) functions as tumor suppressor via inhibiting proliferation, preventing colony formation and inducing apoptosis in breast cancer cells.</a> October 15  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22901165/'>Loss of DBC2 expression is an early and progressive event in the development of lung adenocarcinoma.</a> January 23  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23062488/'>Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression.</a> March 22  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23062450/'>[Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].</a> April 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23546941/'>Decreased expression of the DBC2 gene and its clinicopathological significance in breast cancer: correlation with aberrant DNA methylation.</a> January 28  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24485767/'>The mutation of DBC2 in breast cancer patients from the Han ethnic group in Eastern China.</a> January 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26076810/'>DNA methylation as a promising landscape: A simple blood test for breast cancer prediction.</a> October 27  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27941885/'>DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer.</a> December 13  2016<br></body></html>
